HIV and club drugs in emerging adulthood

Current Opinion in Pediatrics

Volumn 24, Issue 2, 2012, Pages

  Zuckerman, Matthew D ^a   Boyer, Edward W ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

adolescent; amphetamine; club drugs; HIV; MDMA; sexual risk

Indexed keywords

AMPHETAMINE; COCAINE; ILLICIT DRUG; KETAMINE; METHAMPHETAMINE;

ADULTHOOD; AFRICAN AMERICAN; ATTITUDE; DRUG ABUSE; HEALTH BELIEF; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNOWLEDGE; MALE HOMOSEXUAL; NEUROPHARMACOLOGY; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; VIRUS TRANSMISSION;

ADOLESCENT; DRUG UTILIZATION; HIV INFECTIONS; HUMANS; RISK-TAKING; SEXUAL BEHAVIOR; STREET DRUGS; YOUNG ADULT;

EID: 84859111460     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32834faa9b     Document Type: Review

References (105)

1. CDC. HIV Surveillance Report. 2009.
2. Committee on Pediatric AIDS. Reducing the risk of hIV infection associated with illicit drug use. Pediatrics 2006; 117:566-571.
3. CDC. HIV/AIDS Surveillance Report. 2002.
4. Gebo KA, Fleishman JA, Conviser R, et al. Contemporary costs of hIV healthcare in the HAART era. AIDS 2010; 24:2705-2715.
5. Longini IM, Clark WS, Byers RH, et al. Statistical analysis of the stages of HIV infection using a Markov model. Stat Med 1989; 8:831-843. (Pubitemid 19178943)
6. Balaji A, Lowry R, Brener N, et al. Trends in HIV- and STD-related risk behaviors among high school students - United States, 1991-2007. MMWR Morb Mortal Wkly Rep 2008; 57:817-822.
7. Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr 2010; 53:619-624.
8. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of hIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20:1447-1450. (Pubitemid 43948252)
9. McKenna MT, Hu X. Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States. Am J Obstet Gynecol 2007; 197:S10-S16. (Pubitemid 47347968)
10. Sansom SL, Harris NS, Sadek R, et al. Toward elimination of perinatal human immunodeficiency virus transmission in the United States: effectiveness of funded prevention programs, 1999-2001. Am J Obstet Gynecol 2007; 197:S90-S95. (Pubitemid 47370991)
11. Inungu J, Lewis A, Mustafa Y, et al. HIV testing among adolescents and youth in the United States: update from the 2009 Behavioral Risk Factor Surveillance System. Open AIDS J 2011; 5:80-85. This article highlights the poor rate of testing in the adolescent population.
12. Brener N, Kann L, Lowry R, et al. Trends in HIV-related risk behaviors among high school students - United States, 1991-2005. MMWR Morb Mortal Wkly Rep 2006; 55:851-854. (Pubitemid 44291125)
13. Campsmith ML, Rhodes P, Hall HI, et al. HIV prevalence estimates -United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:1073-1076.
14. Johnston LD, Bachman JG, Schulenberg JE. Monitoring the future national results on adolescent drug use: overview of key findings. Ann Arbor: Institute for Social Research, The University of Michigan; 2010. This article highlights the prevalence of club drug use in pediatric populations and how perceptions of safety correlate with rates of use.
15. Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and noninjection drug users. J Urban Health 2003; 80:iii7-iii14. (Pubitemid 38155473)
16. Catania JA, Osmond D, Stall RD, et al. The continuing HIV epidemic among men who have sex with men. Am J Public Health 2001; 91:907-914. (Pubitemid 32496735)
17. Chesney MA, Barrett DC, Stall R. Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health 1998; 88:113-116. (Pubitemid 28109654)
18. Clatts MC, Goldsamt L, Neaigus A, Welle DL. The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research. J Urban Health 2003; 80:iii26-iii39. (Pubitemid 38155475)
19. Clatts MC,Goldsamt LA, Yi H. Club drug use among young men who have sex with men in NYC: a preliminary epidemiological profile. Subst Use Misuse 2005; 40:1317-1330.
20. Clatts MC, Goldsamt LA, Yi H. Drug and sexual risk in four men who have sex with men populations: evidence for a sustained HIV epidemic in New York City. J Urban Health 2005; 82:i9-i17. (Pubitemid 41442799)
21. Fisher DG, Malow R, Rosenberg R, et al. Recreational viagra use and sexual risk among drug abusing men. Am J Infect Dis 2006; 2:107-114.
22. Green AI, Halkitis PN. Crystal methamphetamine and sexual sociality in an urban gay subculture: an elective affinity. Cult Health Sex 2006; 8:317-333. (Pubitemid 44122936)
23. Halkitis PN, Mukherjee PP, Palamar JJ. Longitudinal modeling of methamphetamine use and sexual risk behaviors in gay and bisexual men. AIDS Behav 2009; 13:783-791.
24. Worth H, Rawstorne P. Crystallizing the HIV epidemic: methamphetamine, unsafe sex, and gay diseases of the will. Arch Sex Behav 2005; 34:483-486. (Pubitemid 41428008)
25. Waldo CR, McFarland W, Katz MH, et al. Very young gay and bisexual men are at risk for HIV infection: the San Francisco Bay Area Young Men's Survey II. J Acquir Immune Defic Syndr 2000; 24:168-174. (Pubitemid 30640963)
26. Valleroy LA, MacKellar DA, Karon JM, et al. HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA 2000; 284:198-204. (Pubitemid 30460863)
27. Thiede H, Jenkins RA, Carey JW, et al. Determinants of recent HIV infection among Seattle-area men who have sex with men. Am J Public Health 2009; 99 (Suppl. 1):S157-S164.
28. Stall R, Purcell DW. Intertwining epidemics: areview of research on substance use among men who have sex with men and its connection to the AIDS epidemic. AIDS 2000; 4:181-192. (Pubitemid 30421775)
29. Frankowski BL. Sexual orientation and adolescents. Pediatrics 2004; 113:1827-1832. (Pubitemid 38698004)
30. Talley AE, Sher KJ, Littlefield AK. Sexual orientation and substance use trajectories in emerging adulthood. Addiction 2010; 105:1235-1245.
31. Hutton HE, Lyketsos CG, Zenilman JM, et al. Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. Am J Psychiatry 2004; 161:912-914. (Pubitemid 38625347)
32. DiClemente RJ, Ponton LE. HIV-related risk behaviors among psychiatrically hospitalized adolescents and school-based adolescents. Am J Psychiatry 1993; 150:324-325. (Pubitemid 23046523)
33. Rowe CL, Wang W, Greenbaum P, Liddle HA. Predicting HIV/STD risk level and substance use disorders among incarcerated adolescents. J Psychoactive Drugs 2008; 40:503-512.
34. Tolou-Shams M, Brown LK, Gordon G, Fernandez I. Arrest history as an indicator of adolescent/young adult substance use and HIV risk. Drug Alcohol Depend 2007; 88:87-90. (Pubitemid 46402961)
35. Waller MW, Hallfors DD, Halpern CT, et al. Gender differences in associations between depressive symptoms and patterns of substance use and risky sexual behavior among a nationally representative sample of U.S. adolescents. Arch Womens Ment Health 2006; 9:139-150. (Pubitemid 44020373)
36. Williams CT, Latkin CA. The role of depressive symptoms in predicting sex with multiple and high-risk partners. J Acquir Immune Defic Syndr 2005; 38:69-73. (Pubitemid 40094122)
37. Anderson JE, Freese TE, Pennbridge JN. Sexual risk behavior and condom use among street youth in Hollywood. Fam Plann Perspect 1994; 26:22-25. (Pubitemid 24046764)
38. Walters AS. HIV prevention in street youth. J Adolesc Health 1999; 25:187-198.
39. KipkeMD, Weiss G, Ramirez M, et al. Club drug use in los angeles among young men who have sex with men. Subst Use Misuse 2007; 42:1723-1743. (Pubitemid 47575080)
40. Kubicek K, McDavitt B, Carpineto J, et al. Making informed decisions: how attitudes and perceptions affect the use of crystal, cocaine and ecstasy among young men who have sex with men. J Drug Issues 2007; 37:643-674.
41. Grov C, Kelly BC, Parsons JT. Polydrug use among club-going young adults recruited through time-space sampling. Subst Use Misuse 2009; 44:848-864.
42. Van Leeuwen JM, Hopfer C, Hooks S, et al. A snapshot of substance abuse among homeless and runaway youth in Denver, Colorado. J Community Health 2004; 29:217-229. (Pubitemid 39024023)
43. Das-Douglas M, Colfax G, Moss AR, et al. Tripling of methamphetamine/ amphetamine use among homeless and marginally housed persons, 1996-2003. J Urban Health 2008; 85:239-249.
44. Laurencin CT, Christensen DM, Taylor ED. HIV/AIDS and the African-American community: a state of emergency. J Natl Med Assoc 2008; 100:35-43. (Pubitemid 351224254)
45. Sutton MY, Jones RL, Wolitski RJ, et al. A review of the Centers for Disease Control and Prevention's response to the HIV/AIDS crisis among Blacks in the United States 1981-2009. Am J Public Health 2009; 99 (Suppl.2):S351-S359.
46. Büttner A. Review: the neuropathology of drug abuse. Neuropathol Appl Neurobiol 2011; 37:118-134. This article reviews the drug effects on brain neurotransmitters and receptors as well as systemic physiologic effects.
47. Seger D. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation. Clin Toxicol (Phila) 2010; 48:695-708. This article reviews the neuroadaption that occurs following exposure to cocaine, metamfetamine, and MDMA.
48. Steele TD, McCann UD, Ricaurte GA. 3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and toxicology in animals and humans. Addiction 1994; 89:539-551. (Pubitemid 24160082)
49. Buchanan JF, Brown CR. 'Designer drugs'. Aproblem in clinical toxicology. Med Toxicol Adverse Drug Exp 1988; 3:1-17. (Pubitemid 18078193)
50. Liechti ME, Baumann C, Gamma A, Vollenweider FX. Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology: of ficial publication of the American College of Neuropsychopharmacology 2000; 22:513-521.
51. Britt GC, McCance-Katz EF. A brief overview of the clinical pharmacology of 'club drugs'. Subst Use Misuse 2005; 40:1189-1201.
52. Schenk S. MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research. Neuropsychobiology 2009; 60:130-136.
53. Nichols DE. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs 1986; 18:305-313. (Pubitemid 17231261)
54. Eiserman JM, Diamond S, Schensul JJ. Rollin' on E': aqualitative analysis of ecstasy use among inner city adolescents and young adults. J Ethn Subst Abuse 2005; 4:9-38. (Pubitemid 41698184)
55. Parrott A. MDMA (3,4-Methylenedioxymethamphetamine) orecstasy: the neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology 2004; 50:329-335. (Pubitemid 39482673)
56. Wolff K, Winstock AR. Ketamine: from medicine tomisuse. CNS Drugs 2006; 20:199-218.
57. Stirling J, McCoy L. Quantifying the psychological effects of ketamine: from euphoria to the k-hole. Subst Use Misuse 2010; 45:2428-2443.
58. Morgan CJ, Monaghan L, Curran HV. Beyond the K-hole: a3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Addiction 2004; 99:1450-1461. (Pubitemid 39490532)
59. Morgan CJ, Curran HV. Ketamine use: areview. Addiction 2011; 107:1-12.
60. Romanelli F, Smith KM. Recreational use of sildenafil by HIV-positive and -negative homosexual/bisexual males. Ann Pharmacother 2004; 38:1024-1030. (Pubitemid 38657747)
61. Smith KM, Romanelli F. Recreational use and misuse of phosphodiesterase 5 inhibitors. J Am Pharm Assoc 2005; 45:63-72; quiz 73-75.
62. Lampinen TM, Mattheis K, Chan K, Hogg RS. Nitrite inhalant use among young gay and bisexual men in Vancouver during a period of increasing HIV incidence. BMC Public Health 2007; 7:35-40.
63. Boyer EW, Fay RJ, Cook A, et al. Conducting drug abuse investigations in natural environments: potential directions for medical toxicology research. J Med Toxicol 2010; 6:56-62. Pivotal article discusses novel approach to medical toxicology that obtains information on drug use patterns and associated behaviors in natural environments by hidden populations.
64. Case P. Personal communication regarding results from RO1 DA-12334: HIV risk and club drugs among MSM: a two city comparison. 2003.
65. Schenk S, Gittings D, Johnstone M, Daniela E. Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology (Berl) 2003; 169:21-27. (Pubitemid 37088610)
66. Clemens KJ, McGregor IS, Hunt GE, Cornish JL. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug Alcohol Rev 2007; 26:9-15.
67. McKirnan DJ, Ostrow DG, Hope B. Sex, drugs and escape: a psychological model of HIV-risk sexual behaviours. AIDS Care 1996; 8:655-669. (Pubitemid 27022857)
68. Yi H, Sandfort TGM, Shidlo A. Effects of disengagement coping with HIV risk on unprotected sex among HIV-negative gay men in New York City. Health psychology: of ficial journal of the Division of Health Psychology. Am Psychol Assoc 2010; 29:205-214. This article surveyed HIV-seronegative MSM about attitudes toward sexual behaviors and drug use, and it posits that stressing the harms of unsafe sexual practices may lead to increased drug use in an attempt to disengage.
69. Colfax G, Guzman R. Club drugs and HIV infection: a review. Clin Infect Dis 2006; 42:1463-1469.
70. Romanelli F, Smith KM, Thornton AC, Pomeroy C. Poppers: epidemiology and clinical management of inhaled nitrite abuse. Pharmacotherapy 2004; 24:69-78. (Pubitemid 38056253)
71. Semple SJ, Strathdee SA, Zians J, Patterson TL. Factors associatedwith sex in the context of methamphetamine use in different sexual venues among HIV-positive men who have sex with men. BMC Public Health 2010; 10:178-183.
72. Clatts MC, Goldsamt LA, Yi H. An emerging HIV risk environment: a preliminary epidemiological profile of an MSM POZ Party in New York City. Sex Transm Infect 2005; 81:373-376. (Pubitemid 41494349)
73. Friedman SR, Mateu-Gelabert P, Sandoval M. Group sex events amongst nongay drug users: an understudied risk environment. Int J Drug Policy 2011; 22:1-8. This article discusses the HIV sexual risk behaviors and noninjection drug use in non-MSM group sex venues.
74. Chan Y-F, Passetti LL, Garner BR, et al. HIV risk behaviors: risky sexual activities and needle use among adolescents in substance abuse treatment. AIDS Behav 2011; 15:114-124. This article samples adolescents in substance abuse treatment to discover the effects on HIV risk behaviors and in specific subgroups.
75. Miller BA, Furr-Holden D, Johnson MB, et al. Biological markers of drug use in the club setting. J Stud Alcohol Drugs 2009; 70:261-268.
76. Semple SJ, Strathdee SA, Zians J, Patterson TL. Correlates of trading sex for methamphetamine in a sample of HIV-negative heterosexual methamphetamine users. J Psychoactive Drugs 2011; 43:79-88.
77. Reuben J, Serio-Chapman C, Welsh C, et al. Correlates of current transactional sex among a sample of female exotic dancers in Baltimore, MD. J Urban Health 2011; 88:342-351.
78. Purcell DW, Moss S, Remien RH, et al. Illicit substance use, sexual risk, and HIV-positive gay and bisexual men: differences by serostatus of casual partners. AIDS 2005; 19 (Suppl. 1):S37-S47.
79. Kubicek K, Weiss G, Iverson EF, Kipke MD. Deconstructing the complexity of substance use among young men who have sex with men (YMSM) by optimizing the role of qualitative strategies in a mixed methods study. Subst Use Misuse 2010; 45:754-776. This article examines the qualitative interviews with MSM to obtain information about attitudes toward drug use.
80. Stone E, Heagerty P, Vittinghoff E, et al. Correlates of condom failure in a sexually active cohort of men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:495-501. (Pubitemid 29198290)
81. Bamberger JD, Waldo CR, Gerberding JL, Katz MH. Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault. Am J Med 1999; 106:323-326. (Pubitemid 29153411)
82. Silverman JG, Raj A, Clements K. Dating violence and associated sexual risk and pregnancy among adolescent girls in the United States. Pediatrics 2004; 114:e220-e225.
83. Lang DL, Sales JM, Salazar LF, et al. Rape victimization and high risk sexual behaviors: longitudinal study of African-American adolescent females. West J Emerg Med 2011; 12:333-342.
84. Davis KC, Schraufnagel TJ, George WH, Norris J. The use of alcohol and condoms during sexual assault. Am J Mens Health 2008; 2:281-290.
85. Varela M, Nogué S, Orós M, Miró O. Gamma hydroxybutirate use for sexual assault. Emerg Med J 2004; 21:255-256. (Pubitemid 38344657)
86. Schwartz RH, Milteer R, LeBeau MA. Drug-facilitated sexual assault ('date rape'). South Med J 2000; 93:558-561. (Pubitemid 34263224)
87. Németh Z, Kun B, Demetrovics Z. The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review. J Psychopharmacol 2010; 24:1281-1287.
88. Jansen KLR, Theron L. Ecstasy (MDMA), methamphetamine, and date rape (drug-facilitated sexual assault): a consideration of the issues. J Psychoactive Drugs 2006; 38:1-12.
89. Rudy ET, Shoptaw S, Lazzar M, et al. Methamphetamine use and other club drug use differ in relation to HIV status and risk behavior among gay and bisexual men. Sex Transm Dis 2009; 36:693-695.
90. Colfax GN, Vittinghoff E, Grant R, et al. Frequent methamphetamine use isassociated with primary nonnucleoside reverse transcriptase inhibitor resistance. AIDS 2007; 21:239-241. (Pubitemid 46036934)
91. Wynn GH, Cozza KL, Zapor MJ, et al. Med-psych drug-drug interactions update. Antiretrovirals, part III: antiretrovirals and drugs of abuse. Psychosomatics 2005; 46:79-87.
92. Antoniou T, Tseng AL-I. Interactions between recreational drugs and antiretroviral agents. Ann Pharmacother 2002; 36:1598-1613.
93. Büttner A. Review: the neuropathology of drug abuse. Neuropathol Appl Neurobiol 2011; 37:118-134. [46]
94. Boyer EW, Fay RJ, Cook A, et al. Conducting drug abuse investigations in natural environments: potential directions for medical toxicology research. J Med Toxicol 2010; 6:56-62. [63]
95. Chan Y-F, Passetti LL, Garner BR, et al. HIV risk behaviors: risky sexual activities and needle use among adolescents in substance abuse treatment. AIDS Behav 2011; 15:114-124. [74]
96. Chawarski MC, Zhou W, Schottenfeld RS. Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: A pilot randomized clinical trial. Drug Alcohol Depend 2011; 115:237-239.
97. Friedman SR, Mateu-Gelabert P, Sandoval M. Group sex events amongst nongay drug users: an understudied risk environment. Int J Drug Policy 2011; 22:1-8. [73]
98. Halkitis PN, Pollock JA, Pappas MK, Dayton A, et al. Substance Use in the MSM Population of New York City during the Era of HIV/AIDS. Subst Use Misuse 2011; 46:264-273.
99. Inungu J, Lewis A, Mustafa Y, et al. HIV testing among adolescents and youth in the United States: update from the 2009 Behavioral Risk Factor Surveillance System. Open AIDS J 2011; 5:80-85. [11]
100. Johnston LD, Bachman JG, Schulenberg JE. Monitoring the future national results on adolescent drug use: overview of key findings. Ann Arbor: Institute for Social Research, The University of Michigan; 2010. [14]
101. Kubicek K, Weiss G, Iverson EF, Kipke MD. Deconstructing the complexity of substance use among young men who have sex with men (YMSM) by optimizing the role of qualitative strategies in a mixed methods study. Subst Use Misuse 2010; 45:754-776. [79]
102. Lee CM, Chang FC, Miao NF, Shyu ML, et al. Effects of aCommunity Prevention Intervention on Public Awareness, Knowledge, and Risk Perception of Club Drug Use by Youth in Taiwan. Subst Use Misuse 2011; 46:1265-1274.
103. Lemstra M, Rogers M, Thompson A, Moraros J, et al. Risk Indicators of depressive Symptomatology Among Injection Drug Users and Increased HIV Risk Behaviour. Can J Psychiat-Rev Can Psychiat 2011; 56:358-366.
104. Seger D. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation. Clin Toxicol (Phila) 2010; 48:695-708. [47]
105. Yi H, Sandfort TGM, Shidlo A. Effects of disengagement coping with HIV risk on unprotected sex among HIVnegative gay men in New York City. Health psychology: of ficial journal of the Division of Health Psychology. Am Psychol Assoc 2010; 29:205-214. [68]